Cited by 96Sepsis Diagnosis and TreatmentRespiratory Support and MechanismsAngiogenesis and VEGF in Cancer

Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality

Open access
David, Sascha, Ghosh, Chandra C., Kümpers, Philipp, Shushakova, Nelli, Van Slyke, Paul, Khankin, Eliyahu V., Karumanchi, S. Ananth, Dumont, Dan +1 more·2011·American Journal of Physiology-Lung Cellular and Molecular Physiology

Abstract

A synthetic 7-mer, HHHRHSF, was recently identified by screening a phage display library for binding to the Tie-2 receptor. A polyethylene-oxide clustered version of this peptide, termed vasculotide (VT), was reported to activate Tie-2 and promote angiogenesis in a mouse model of diabetic ulcer. We hypothesized that VT administration would defend endothelial barrier function against sepsis-associated mediators of permeability, prevent lung vascular leakage arising in endotoxemia, and improve mortality in endotoxemic mice. In confluent human microvascular endothelial cells, VT prevented endotoxin-induced (lipopolysaccharides, LPS O111:B4) gap formation, loss of monolayer resistance, and translocation of labeled albumin. In 8-wk-old male C57Bl6/J mice given a ∼70% lethal dose of endotoxin (15 mg/kg ip), VT prevented lung vascular leakage and reversed the attenuation of lung vascular endothelial cadherin induced by endotoxemia. These protective effects of VT were associated with activation of Tie-2 and its downstream mediator, Akt. Echocardiographic studies showed only a nonsignificant trend toward improved myocardial performance associated with VT. Finally, we evaluated survival in this mouse model. Pretreatment with VT improved survival by 41.4% ( n = 15/group, P = 0.02) and post-LPS administration of VT improved survival by 33.3% ( n = 15/group, P = 0.051). VT-mediated protection from LPS lethality was lost in Tie-2 heterozygous mice, in agreement with VT's proposed receptor specificity. We conclude that this synthetic Tie-2 agonist, completely unrelated to endogenous Tie-2 ligands, is sufficient to activate the receptor and its downstream pathways in vivo and that the Tie-2 receptor may be an important target for therapeutic evaluation in conditions of pathological vascular leakage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajplung.00459.2010

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
David, S., Ghosh, C. C., Kümpers, P., Shushakova, N., Van Slyke, P., Khankin, E. V., Karumanchi, S. A., Dumont, D., & Parikh, S. M.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • University Hospital Münster (DE)
  • Medizinische Hochschule Hannover (DE)
  • Molecular and Cellular Biology Research, Sunnybrook Research Institute, and Department of Medical Biophysics, University of Toronto, Ontario, Canada; and
  • University of Toronto (CA)
Corresponding author
Parikh, Samir M.
Venue
American Journal of Physiology-Lung Cellular and Molecular Physiology
Published
2011-06
Volume
300
Issue
6
Pages
L851-L862
ISSN
  • 1040-0605 (ISSN-L)
  • 1522-1504
OpenAlex
W2169581734
Cited by
96
References
40
Citations by year
2026: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 9 · 2020: 6 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 6 · 2015: 13 · 2014: 8 · 2013: 8 · 2012: 10
FWCI
6.96
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Lung Cellular and Molecular Physiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL093234)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08DK06916)
Topics
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
Tie2 receptor, PEGylated peptide, endotoxemia, lipopolysaccharide, sepsis, lung injury, vascular leakage, endothelial barrier function, Akt signaling, survival, angiogenesis, phage display peptides
MeSH terms
Animals, Capillary Permeability, Endothelium, Vascular, Endotoxins, Humans, Immunoenzyme Techniques, Lipopolysaccharides, Male, Mice, Inbred C57BL, Peptide Fragments, Polyethylene Glycols, RNA, Messenger, Blotting, Western, Survival Rate, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Receptor, TIE-2, Mice, Lung Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review